Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RBMX2P5 (RNA binding motif protein, X-linked 2 pseudogene 5) is a noncoding pseudogene of the RBMX2 gene in humans. Pseudogenes such as RBMX2P5 arise from duplication or retrotransposition events and typically do not encode functional proteins[2][5]. Instead, some pseudogenes are expressed as RNA and can regulate their parent genes by acting as microRNA decoys or via other regulatory RNA functions; however, there is no specific evidence that RBMX2P5 is clinically relevant in this manner[4][7]. There is *no indication* that RBMX2P5 is a **therapeutic target** (such as a receptor, enzyme, transporter, or transcription factor), nor is it classified under any canonical druggable family. It does not have known disease associations, interact with drugs, or act as a biomarker for disease or therapy response based on current scientific literature and gene/protein databases[2][5][4]. RBMX2P5 is a human pseudogene, not a therapeutic target, and is not considered relevant for drug discovery or clinical biomarker development. It should not be listed as a canonical target[2][4][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA binding motif protein, X-linked 2 pseudogene 5 (RBMX2P5).